Fresenius SE & Co. KGaA (FSNUY)
OTCMKTS · Delayed Price · Currency is USD
13.95
-0.38 (-2.65%)
At close: Dec 16, 2025
Fresenius SE & Co. KGaA Market Cap
Fresenius SE & Co. KGaA has a market cap or net worth of $31.45 billion as of December 16, 2025. Its market cap has increased by 55.97% in one year.
Market Cap
31.45B
Enterprise Value
45.37B
Revenue
26.33B
Ranking
n/a
PE Ratio
23.45
Stock Price
$13.95
Market Cap Chart
Since April 23, 1997, Fresenius SE & Co. KGaA's market cap has increased from 2.17B to 31.45B, an increase of 1,349.53%. That is a compound annual growth rate of 9.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 16, 2025 | 31.45B | 60.48% |
| Dec 30, 2024 | 19.60B | 12.16% |
| Dec 29, 2023 | 17.48B | 10.60% |
| Dec 30, 2022 | 15.80B | -29.41% |
| Dec 30, 2021 | 22.38B | -13.65% |
| Dec 30, 2020 | 25.92B | -17.36% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 841.30M |
| Glass House Brands | 743.26M |
| Elite Pharmaceuticals | 537.17M |
| CytoDyn | 407.36M |
| Northwest Biotherapeutics | 368.73M |
| American Oncology Network | 365.47M |
| Silence Therapeutics | 298.52M |
| Nika Pharmaceuticals | 291.10M |